The surgical treatment of a patient with localized renal cancer and chronic renal failure following a course of stereotactic radiotherapy
G. V. Gilivanova,
E. A. Kipriyanov,
P. A. Karnaukh,
K. Y. Ivakhno,
A. A. Peretrukhin,
M. A. Zolotykh,
M. T. Beydzhanov,
D. M. Rostovtsev https://doi.org/10.21886/2308-6424-2024-12-5-82-87
Abstract
The basic treatment approach for clinically localized and locally advanced renal cell cancer (RCC) is surgery. Kidney resection is the preferred organ-preserving approach to surgical treatment. For high-risk patients with operative treatment or with somatic contraindications to surgery, an alternative treatment option like stereotactic radiotherapy may be considered. The article presents a clinical case of a 63-year-old patient with the diagnosis: Left kidney cancer T1aN0M0, stage I. C3a CKD. In April 2021, a course of stereotactic radiotherapy was performed on the kidney tumor up to SOD 45 Gy. In June 2022, left kidney resection was performed for PCC progression. Recurrence-free and cancerspecific survival rate was 20 months.
About the Authors
G. V. Gilivanova
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine
Russian Federation
Russian Federation
Galina V. Gilivanova
Chelyabinsk
E. A. Kipriyanov
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine ; South Ural State Medical University
Russian Federation
Russian Federation
Evgeny A. Kipriyanov — Cand.Sc.(Med)
Chelyabinsk
P. A. Karnaukh
South Ural State Medical University
Russian Federation
Russian Federation
Peter A. Karnaukh — Dr.Sc.(Med)
Chelyabinsk
K. Y. Ivakhno
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine
Russian Federation
Russian Federation
Konstantin Y. Ivakhno — Cand.Sc.(Med)
Chelyabinsk
A. A. Peretrukhin
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine
Russian Federation
Russian Federation
Andrey A. Peretrukhin
Chelyabinsk
M. A. Zolotykh
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine
Russian Federation
Russian Federation
Maxim A. Zolotykh — Cand.Sc.(Med)
Chelyabinsk
M. T. Beydzhanov
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine
Russian Federation
Russian Federation
Marif T. Beydzhanov
Chelyabinsk
D. M. Rostovtsev
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine ; South Ural State Medical University
Russian Federation
Russian Federation
Dmitry M. Rostovtsev — Dr.Sc.(Med)
Chelyabinsk
References
1. Axel E.M., Matveev V.В. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Cancer Urology. 2019;15(2):15-24. (In Russian). DOI: 10.17650/1726-9776-2019-15-2-15-24
2. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913-924. DOI: 10.1016/j.eururo.2015.01.005
3. Cancer of the renal parenchyma. The rubricator of clinical recommendations of the Ministry of Health of the Russian Federation. (In Russian). Accessed on 03.03.2024. URL: https://cr.minzdrav.gov.ru/schema/10_4
4. Oganyan V.A., Karelskaya N.A., Monakov D.M., Demidova V.S., Lebedeva A.N., Gritskevich A.A. Robot-assisted partial nephrectomy in difficult renal masses using isolated combined ‘drug & cold’ ischemia in situ. Urology Herald. 2024;12(5):96-104. (In Russian). DOI: 10.21886/2308-6424-2024-12-5-96-104
5. Kotov S.V., Guspanov R.I., Yusufov A.G., Nemenov A.A., Mantsov A.A. Effect of adherent perinephric fat on outcomes of nephron-sparing treatment of renal cell cancer. Urology Herald. 2023;11(2):47-55. (In Russian). DOI: 10.21886/2308-6424-2023-11-2-47-55
6. Ivakhno K.Yu., Vazhenin A.V., Karnaukh P.A., Gallyamova Yu.V., Vazhenin I.A. The first experience of using a robotic system for stereotactic hyprofractive radiotherapy "Cybernoj" in the treatment of patients with renal cell carcinoma. Tyumen Medical Journal. 2015;17(1):28-31. (In Russian). eLIBRARY ID: 23867907; EDN: UCHVOF
7. Seregin A.A., Seregin A.V., Kolontarev K.B., Pushkar D.Yu., Loran O.B. Open, laparoscopic, and robotic techniques for partial nephrectomy for renal cell carcinoma: a comparison of outcomes based on "trifecta" and "pentafecta" criteria. Urology Herald. 2024;12(2):66-75. (In Russian). DOI: 10.21886/2308-6424-2024-12-2-66-75
8. Rakul S.A., Pozdnyakov K.V., Eloev R.A. Long-term oncological results of surgical treatment of localized renal tumors. Cancer Urology. 2021;17(4):27-37. (In Russian). DOI: 10.17650/1726-9776-2021-17-4-27-37
9. Senger C, Conti A, Kluge A, Pasemann D, Kufeld M, Acker G, Lukas M, Grün A, Kalinauskaite G, Budach V, Waiser J, Stromberger C. Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function. BMC Urol. 2019;19(1):96. DOI: 10.1186/s12894-019-0531-z
10. Correa RJM, Louie AV, Staehler M, Warner A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh BS, Lo SS, Muacevic A, Siva S. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK. J Urol. 2019;201(6):1097-1104. DOI: 10.1097/JU.0000000000000111
11. Siva S, Pham D, Kron T, Bressel M, Lam J, Tan TH, Chesson B, Shaw M, Chander S, Gill S, Brook NR, Lawrentschuk N, Murphy DG, Foroudi F. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. BJU Int. 2017;120(5):623-630. DOI: 10.1111/bju.13811
12. Chernichenko AV, Kornilov IV, Vorobyov NV, Plavnik RN, Golbits AB, Leontyev AV, Gerasimov VA. Stereotactic body radiation therapy for early stage of kidney cancer. P.A. Herzen Journal of Oncology. 2024;13(5):5 11. (In Russian). DOI: 10.17116/onkolog2024130515
13. Stepanovich E.A., Demeshko P.D., Polyakov S.L., Minailo I.I. Stereotaksicheskaya luchevaya terapiya pri pochechno-kletochnom rake. Opyt i neposredstvennye rezul'taty. Malignant tumours. 2022;12(3s1):57-61. (In Russian). DOI: 10.18027/2224-5057-2022-12-3s1-57-61
Review
For citations:
Gilivanova G.V., Kipriyanov E.A., Karnaukh P.A., Ivakhno K.Y., Peretrukhin A.A., Zolotykh M.A., Beydzhanov M.T., Rostovtsev D.M. The surgical treatment of a patient with localized renal cancer and chronic renal failure following a course of stereotactic radiotherapy. Urology Herald. 2025;13(1):82-87. (In Russ.) https://doi.org/10.21886/2308-6424-2024-12-5-82-87
Views:
418
Email this article 
